PHARMA EVIDENCE ApS: Financial statements 2024
CVR: 34586519
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -157,709 and a net result of DKK -179,749 compared with DKK -796,106 the year before. Equity in the 2024 report amounted to DKK 72,254. The solvency ratio was 34.1%.
- Gross Profit
- DKK -157,709
- Profit/Loss
- DKK -179,749
- Equity
- DKK 72,254
- Total Assets
- DKK 211,766
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -158 t. | -180 t. | 72 t. | 0 |
| 2023 | - | -428 t. | -796 t. | 252 t. | 1 |
| 2022 | - | 552 t. | 197 t. | 1 mio. | 1 |
| 2021 | - | 196 t. | -442 t. | 851 t. | 1 |
| 2020 | - | 1.1 mio. | 643 t. | 1.3 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PHARMA EVIDENCE ApS has published its annual report for 2023. Gross profit came to DKK -428,457, and the net result was DKK -796,106.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity in the 2025 report amounted to DKK 134,401.